These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 431401)

  • 1. A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies.
    Keating MJ; Bodey GP; Valdivieso M; Rodriguez V
    Medicine (Baltimore); 1979 Mar; 58(2):159-70. PubMed ID: 431401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    Zinner SH; Dudley M; Blaser J
    Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
    Lau WK; Young LS; Black RE; Winston DJ; Linne SR; Weinstein RJ; Hewitt WL
    Am J Med; 1977 Jun; 62(6):959-66. PubMed ID: 586099
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative trial of sisomicin therapy by intermittent versus continuous infusion.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    Am J Med Sci; 1977; 274(2):179-88. PubMed ID: 602958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin therapy of infections in neutropenic patients.
    Valdivieso M; Feld R; Rodriguez V; Bodey GP
    Am J Med Sci; 1975; 270(3):453-63. PubMed ID: 1108649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
    Martino P; Venditti M; Petti MC; Mandelli F; Serra P
    Infection; 1985; 13(3):125-9. PubMed ID: 3928495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
    Klastersky J; Hensgens C; Meunier-Carpentier F
    J Infect Dis; 1976 Nov; 134 SUPPL():S433-40. PubMed ID: 792359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
    J Clin Oncol; 1983 Oct; 1(10):597-603. PubMed ID: 6366126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.
    Bodey GP; Feld R; Burgess MA
    Am J Med Sci; 1976; 271(2):179-86. PubMed ID: 773180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
    Maltezou HC; Baka M; Gombakis N; Koliouskas DE; Kosmidou H; Malaka-Zafiriou E; Kafetzis DA
    Int J Antimicrob Agents; 2001 Oct; 18(4):383-6. PubMed ID: 11691573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
    Valdivieso M; Bodey GP
    Am J Med Sci; 1977; 273(2):177-84. PubMed ID: 860733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
    Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
    Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
    Love LJ; Schimpff SC; Hahn DM; Young VM; Standiford HC; Bender JF; Fortner CL; Wiernik PH
    Am J Med; 1979 Apr; 66(4):603-10. PubMed ID: 373439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
    Velasco E; Costa MA; Martins CA; Nucci M
    Am J Clin Oncol; 1995 Oct; 18(5):429-35. PubMed ID: 7572762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
    Braine HG; Stuart RK; Saral R; Lietman PS
    Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prevention of bacterial infections during cytostatic chemotherapy.
    Klastersky J
    Acta Clin Belg; 1981; 36(3):162-6. PubMed ID: 7270003
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of amikacin usage in the EORTC trials.
    Zinner SH
    Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin therapy for serious gram-negative infection.
    Pollock AA; Berger SA; Richmond AS; Simberkoff MS; Rahal JJ
    JAMA; 1977 Feb; 237(6):562-4. PubMed ID: 576282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.